Search Within
Document Type
71-63-6
Applied Filters:
Keyword:'71-63-6'
Showing 1-30 of 271 results for "71-63-6" within Technical Documents
SMC®Plate Washer Evaluation Kit
H 97 76 89 77 80 83 85 71 87 88 78 81 83 7 9
Column Mean 78 65 72 63 69 67 65 63 64 73 61 81
SD 10 9 11 12 6 10 12
The Effective Use of Protein Kinase Inhibitors
101 96 28 34 77 28 29 63 104 91 9 92 42 94 111 94 70 22 72 104 101 84
87 110 29 12 12 49 66 28 94 79 20 117 64 43 70 93 71
Specification Sheet: NovAseptic® Mixer Drive Unit, GMP ATEX
0.25 50 1.49/0.86 2858 63/B14
AX1/41 AC75 63B-2 II 2G Ex db eb IIC T4 Gb* 0.25 50 1.49/0.86 2858 63/B14
AX5/41 AC75 63B-2 II 2G Ex db eb IIC T4 Gb* 0.25 50 1.49/0.86 2858 63/B14
The Effective Use of Protein Kinase Inhibitors
101 96 28 34 77 28 29 63 104 91 9 92 42 94 111 94 70 22 72 104 101 84
87 110 29 12 12 49 66 28 94 79 20 117 64 43 70 93 71
Quality Control Ranges: Milliplex Human High Sensitivity T Cell Magnetic Bead Panel
IFNγ Control 1 31 – 63 pg/mL IL-5 Control 1 18 – 38 pg/mL
Control 2 137 – 284 pg/mL Control 2 87 – 181 pg/mL
NovAseptic Mixer, Drive Unit, GMP
Nord™ 63L2 0.25 0.30 1.21 0.7 63/B14
GMP100 Nord™ 63L2 0.25 0.30 1.21 0.7 63/B14
GMP500 Nord™ 71L/2 0.55 0.65 2.17 1.25 71/B14
GMP1000 Nord™ 71L/2 0.55 0.65 2.17 1.25 71/B14
GMP2000 Nord™ 80SH/
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
std
6
26 23 21 26 111 52 35 114 23 63 32 46 40 9184 37
24 21 25 26 108 55 36 116 25 63 33 40 41 8977 40
std
7
37 37
Spec sheet: NovAseptic® Mixer Drive Unit GMP
.25 0.34 0.98/0.57 0.86/0.50 63/B14
GMP100 Nord™ 63LP/2 CUS TF IE3 0.25 0.34 0.98/0.57 0.86/0.50 63/B14
GMP500 Nord™ 71LP/2 CUS TF IE3 0.55 0.74 2.14/1.24 1.87/1.08 71/B14
GMP1000 Nord™ 71LP/2
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
4f145d106s26p3
84 *208.98 254
962
1.76Po
2, 4, 6
[Xe] 4f145d106s26p4
85 *209.99 302
337
1.96At
–1, 1, 3, 5, 7
[Xe] 4f145d106s26p5
86 *222.02 –71
–61.7
Rn
2
[Xe] 4f145d106s26p6
Troglitazone-A potent and selective PPAR agonist
2001).
2. Dautzenberg, F.M. and Hauger, R.L., Trends Pharmacol. Sci., 23, 71-77 (2002).
3. Hoare, S.R., et al., Mol. Pharmacol., 63, 751-765 (2003).
4. Chen, C., et al., J. Med. Chem., 39, 4358-4360 (1996
Data Sheet - S1442
least 6 months, as determined by HPLC.
References
1. Ziegelbauer, K., and Spaltmann, F., Antifungal
agents with protein biosynthesis inhibitory activity.
Drugs of the Future, 25, 63-71 (2000).
Troglitazone- A potent and selective PPAR agonist
2001).
2. Dautzenberg, F.M. and Hauger, R.L., Trends Pharmacol. Sci., 23, 71-77 (2002).
3. Hoare, S.R., et al., Mol. Pharmacol., 63, 751-765 (2003).
4. Chen, C., et al., J. Med. Chem., 39, 4358-4360 (1996
Bulletin - 750332C
): 15-28
• Ritov et al (2006). Analysis of cardiolipin in human muscle biopsy. J Chromatogr B 831:63-71
Related products: cardiolipins
MSDS: see www.avantilipids.com for product number 750332
Bulletin - 710335C
): 15-28
• Ritov et al (2006). Analysis of cardiolipin in human muscle biopsy. J Chromatogr B 831:63-71
Related products: cardiolipins
MSDS: see www.avantilipids.com for product number 710335
Bulletin - 710335P
): 15-28
• Ritov et al (2006). Analysis of cardiolipin in human muscle biopsy. J Chromatogr B 831:63-71
Related products: cardiolipins
MSDS: see www.avantilipids.com for product number 710335
Product Information Sheet - C7521
2731-2739 (2008).
6. Vahedi, K., and Alamowitch, S., Clinical spectrum
of type IV collagen (COL4A1) mutations: a novel
genetic multisystem disease. Curr. Opin. Neurol.,
24, 63-68 (2011).
7. Maruyama
Bulletin - 750332P
): 15-28
• Ritov et al (2006). Analysis of cardiolipin in human muscle biopsy. J Chromatogr B 831:63-71
Related products: cardiolipins
MSDS: see www.avantilipids.com for product number 750332
Product Information - 107360
fertilization, and subsequent development of
bovine oocytes with or without cumulus cells. Biol.
Reprod., 63(6), 1730-1734 (2000).
7. Jiang, X., and Doyle, M. P., Growth supplements
for Helicobacter pylori
Product Information Sheet - C5533
2731-2739 (2008).
6. Vahedi, K., and Alamowitch, S., Clinical spectrum
of type IV collagen (COL4A1) mutations: a novel
genetic multisystem disease. Curr. Opin. Neurol.,
24, 63-68 (2011).
7. Maruyama
Periodic table A4
.98
254
962
1.76
Po
2, 4, 6
[Xe] 4f145d106s26p4
85
*209.99
302
336.95
1.96
At
–1, 1, 3, 5, 7
[Xe] 4f145d106s26p5
86
*222.02
–71
–61.7
CYTOCHROME P450 CYP4A11 ISOZYME Human Recombinant Microsomes with Cytochrome P450 Reductase
regioselectivities fo the
rat and human fatty acid omega-hydroxylases,
Arch. Biochem. Biophys., 373, 63-71 (2000).
4. Guengrich, F.P. Cytochrome P450: Structure,
Mechanism and Biochemistry (2nd Edition
Aldrich Polymer Products Application - Transitions
2,4,6-Trimethylstyrene 162
Vinyl acetal 355 82
Vinyl acetate 30
Vinyl alcohol 85 220
Vinyl benzoate 71
Vinyl 4-tert-butylbenzoate 101 –
Vinyl butyral 322 49
Vinyl carbazole 227 320
Vinyl chloride 81 227
Data Sheet - H4417
2731-2739 (2008).
6. Vahedi, K., and Alamowitch, S., Clinical spectrum
of type IV collagen (COL4A1) mutations: a novel
genetic multisystem disease. Curr. Opin. Neurol.,
24, 63-68 (2011).
7. Maruyama
Data Sheet - A0438
Oxidase
from Hansenula polymorpha
Catalog Number A0438
Storage Temperature –20 C
CAS RN 9073-63-6
EC 1.1.3.13
Synonym: Alcohol:oxygen oxidoreductase
Product Description
Alcohol oxidase catalyzes
Data Sheet - SAB4200632
working dilutions by titration.
References
1. Torok, M., and Etkin, L.D., Differentiation, 67, 63-71
(2001).
2. Lionel, A.C., et al., Sci. Transl. Med., 3, 95ra75
(2011).
3. Lesch, K.P., et
Data Sheet-SCC253
2010, 3: 39-47.
3. Exp Cell Res 1984, 154(1): 38-52.
4. Am J Pathol 1989, 135(1): 63-71.
5. Am J Pathol 1998, 153(6): 1913-1921.
4
Data Sheet - D7657
2. Toxic concentration 34 � 18 (see ref 2)
34 � 6 (see ref 3)
References
1. Butler, V. P., Jr., and Chen, J. P., Proc. Natl.
Acad. Sci., 57, 71 (1967).
2. Beller, G. A., et al., N.
Periodic table Poster
4d105s2
57–71
Lanthanides
Lantánidos
72 178.49 2233
4603
1.23Hf
4
[Xe] 4f145d26s2
73 180.95 3017
5455
1.33Ta
5
[Xe] 4f145d36s2
74 183.84 3422
5555
1.40W
0, 2, 3, 4, 5, 6
[Xe] 4f145d46s2
Product Information Sheet - K0250
stress associated
with the kainic acid rodent model of experimental
epilepsy. Epilepsy Res., 39, 63-71 (2000).
11. Kondratyev, A., and Gale, K., Intracerebral injection
of caspase-3 inhibitor prevents
Data Sheet - SAB4200829
Hig. Med. Dosw.
(Online), 71, 315-327 (2017).
5. Diaz, G.J. et al., Poult. Sci., 89, 2461-9 (2010).
6. de Andrade, C.Y.T. et al., Carbohydr. Polym.,
185, 63-72 (2018).
7. Moon, J. et
Page 1 of 10